Sterling Capital Management LLC Cuts Stock Holdings in Ventas, Inc. $VTR

Sterling Capital Management LLC lowered its position in Ventas, Inc. (NYSE:VTR) by 20.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,852 shares of the real estate investment trust’s stock after selling 14,472 shares during the period. Sterling Capital Management LLC’s holdings in Ventas were worth $4,649,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in VTR. Bridgewater Advisors Inc. raised its stake in shares of Ventas by 2.0% during the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after buying an additional 133 shares in the last quarter. IHT Wealth Management LLC boosted its stake in shares of Ventas by 3.2% in the fourth quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after buying an additional 137 shares in the last quarter. True Wealth Design LLC boosted its stake in shares of Ventas by 32.0% in the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after buying an additional 138 shares in the last quarter. Cigna Investments Inc. New grew its holdings in Ventas by 3.3% during the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after acquiring an additional 142 shares during the period. Finally, Parallel Advisors LLC grew its holdings in Ventas by 4.6% during the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after acquiring an additional 175 shares during the period. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Stock Up 1.9%

VTR opened at $89.06 on Friday. The business’s fifty day moving average is $85.21 and its two-hundred day moving average is $82.79. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The company has a market cap of $43.30 billion, a price-to-earnings ratio of 161.92, a PEG ratio of 1.91 and a beta of 0.71. Ventas, Inc. has a one year low of $61.76 and a one year high of $91.06.

Ventas (NYSE:VTR) last posted its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same period last year, the company posted $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts anticipate that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.3%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is 378.18%.

Insider Activity

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of Ventas stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 0.53% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on VTR shares. KeyCorp increased their price objective on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Jefferies Financial Group upped their price target on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Royal Bank Of Canada increased their price target on shares of Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a report on Monday, May 4th. UBS Group raised their price objective on shares of Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. Finally, Scotiabank decreased their price objective on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $96.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.